Gold Prices Hold Steady as Market Awaits Progress in USIran Peace Talks Post Office Horizon Scandal Police Inquiry Faces FiveYear Delay Without Extra Funding Commander Warns Rigetti Computing Surges 48 on 100 Million Government Backing Announcement Consumer Sentiment Plunges to Record Low in May as Gas Prices Surge Amid Iran Conflict IIT Madras and IIT Kanpur to Support CBSE in Resolving Revaluation Portal Technical Issues SpaceX OpenAI Anthropic Could Surpass Berkshire Hathaway on First Trading Day Prediction Markets Suggest ICHR Q1 2026 Earnings EPS Surpasses Expectations Stock Rises EMN Q1 2026 Earnings Earnings Per Share Beats Estimates Stock Edges Higher TXO Partners Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Challenges NESR Q1 2026 Earnings EPS Surges Past Estimates with 1987 Beat JCTC Q3 2025 Earnings Loss Reported but Stock Rises A Mixed Picture for the SmallCap Distributor CATO Q4 2025 Earnings Negative EPS of 055 as Stock Gains 356 Amid Retail Headwinds Jade Biosciences Inc JBIO Holds Steady as Price Consolidates Near Key Resistance TrioTech International TRT Slips 456 Key Support Test in Play After Sharp Pullback Sila Realty Trust SILA Holds Steady Near 3020 Testing Key Support and Resistance Levels Grupo Aeromexico AERO Edges Higher as Airline Sector Stabilizes Starry Sea Acquisition Corp Rights SSEAR Flat at 017 as Trading Remains Tight European Manufacturers Maintain China Production Amid EU DeRisking Efforts UAL Q1 2026 Earnings EPS Beat Surprises by 10 Amid Positive Travel Demand CryoPort Inc CYRX Faces Selling Pressure as Shares Slip to 140 Key Support Levels in Focus Malibu Boats MBUU Rides Wave of Optimism After 264 Gain Electromed Inc ELMD Holds Steady Near 38 as Stock Consolidates in Tight Range Gyre Therapeutics GYRE Falters Testing Key Support After 194 Decline Krystal Biotech KRYS Edges Higher Key Support and Resistance Levels in Focus Amplitech Group Inc Series A Right AMPGR Surges 975 Key Levels to Watch Iterum Therapeutics ITRM Holds at 003 as Trading Volume Remains Subdued Praxis Precision Medicines PRAX Holds Near Resistance After Slight Pullback